Cargando…
Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a systemic disease that leads to joint destruction. During the last decade, the therapy of RA has been principally based on biological drugs. Although the efficacy of biological therapy has been established, patients demonstrated a high heterogeneity in clinical response...
Autores principales: | Pallio, Giovanni, Mannino, Federica, Irrera, Natasha, Eid, Ali H., Squadrito, Francesco, Bitto, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565539/ https://www.ncbi.nlm.nih.gov/pubmed/32825059 http://dx.doi.org/10.3390/biom10091203 |
Ejemplares similares
-
Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review
por: Lauro, Rita, et al.
Publicado: (2021) -
Atherosclerosis Plaque Reduction by Lycopene Is Mediated by Increased Energy Expenditure through AMPK and PPARα in ApoE KO Mice Fed with a High Fat Diet
por: Mannino, Federica, et al.
Publicado: (2022) -
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury
por: Irrera, Natasha, et al.
Publicado: (2020) -
Biglycan Involvement in Heart Fibrosis: Modulation of Adenosine 2A Receptor Improves Damage in Immortalized Cardiac Fibroblasts
por: Scuruchi, Michele, et al.
Publicado: (2023) -
Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing
por: Galeano, Mariarosaria, et al.
Publicado: (2021)